Transport of amino acids across plasma membrane is mediated by several transport systems in mammalian cells (Christensen, 1990) . We have described an Na ϩ -independent, anionic amino acid transport system that is highly specific for cystine and glutamate in cultured human fibroblasts and mouse peritoneal macrophages (Bannai and Kitamura, 1980; Watanabe and Bannai, 1987) . This system, designated as system x c Ϫ , transports an anionic form of cystine in exchange for glutamate (Bannai, 1986) . The activity of system x c Ϫ is drastically induced by electrophilic agents and oxygen in various cultured cells (Bannai, 1984a; Bannai et al., , 1989 Miura et al., 1992) . The cells expressing system x c Ϫ take up cystine in the medium and reduce it to cysteine (sulfhydryl form), which is in turn used for the synthesis of glutathione and proteins. A part of cysteine is released back into the medium via neutral amino acid transport systems; then cysteine is rapidly oxidized to cystine by oxygen in the medium (Bannai et al., 1989) . Thus, the activity of system x c Ϫ contributes to driving the cystine/ cysteine cycle and to maintaining the balance between cystine and cysteine in the culture medium. In these cultured cells, the activity of system x c Ϫ is also demonstrated to be essential for maintaining the intracellular glutathione levels . Because glutathione is one of the cellular antioxidant systems and plays a central role in eliminating oxidative stress, system x c Ϫ is categorized as the antioxidant defense system, at least in cultured cells. However, it is unknown whether system x c Ϫ functions as an antioxidant defense system in vivo. We have recently isolated cDNAs for this transporter and found that it is composed of two protein components, the surface antigen of 4F2 heavy chain (4F2hc) and a novel protein named xCT (Sato et al., 1999) . xCT has 12 putative transmembrane domains, whereas 4F2hc is predicted to have a single transmembrane domain. It has been shown that in some amino acid transporters, such as systems L and y ϩ L, 4F2hc brings the counterpart light-chain proteins to the surface of the plasma membrane (Mastroberardino et al., 1998; Torrents et al., 1998) . We have shown that the combined expression of xCT and 4F2hc is indispensable for eliciting x c Ϫ activity in Xenopus oocytes (Sato et al., 1999) . Thus, it is likely that 4F2hc functions similarly in system x c Ϫ . In Northern blot analysis, the mRNA for xCT was detected in the mouse brain, but not in the heart, liver, lung, or kidney (Sato et al., 1999) . The activity of system x c Ϫ has been found in primary cultures of rat cortical neurons (Murphy et al., 1990; Ishige et al., 2001) , isolated brain cells from fetal rats (Sagara et al., 1993) , and human glioma cells (Ye et al., 1999) . In the present study, we have investigated the distribution of xCT and 4F2hc mRNAs in the mouse brain by in situ hybridization. The data indicate that system x c Ϫ is robustly expressed in some specific brain regions facing the cerebral ventricles and in meninges, suggesting that this transporter is involved in maintaining the redox state of the CSF in the brain.
MATERIALS AND METHODS
Mouse xC T cDNA digested with PstI (34 -369 bp), mouse xC T cDNA digested with BamHI and HindIII (886 -1843 bp), and mouse 4F2hc cDNA digested with PstI and EcoRI (948 -1793 bp) were subcloned into pBluescript. Each cRNA probe was digoxigenin (DIG)-labeled by tran-scription from the linearized plasmid using RNA-labeling mix (Roche Diagnostics GmbH, Mannheim, Germany) and T3/ T7 RNA polymerase (Stratagene, La Jolla, CA). The in situ hybridization was performed as described previously (Ohto et al., 2002) . Female C57BL /6Cr mice weighing 18 -21 gm were deeply anesthetized with sodium pentobarbital (20 mg / kg, i.p.), perf used, and fixed with 4% paraformaldehyde in PBS, pH 7.4. The brains were excised and postfixed in the same fixative overnight. Then the brains were incubated in 30% sucrose in PBS overnight and embedded with optimal cutting temperature (OC T) compound (Sakura Finetechnical Co., L td., Tokyo, Japan). Sections (10 m) were cut in a cryostat and picked up on Matsunami-aminosilane-coated microscope slides (Matsunami, Osaka, Japan). To remove the OC T compound, the slides were placed in PBS containing 0.1% T ween 20 (PBT) at room temperature twice for 5 min and then incubated in PBT containing 1 gm /ml proteinase K at 37°C for 5 min. The slides were rinsed in PBT three times, fixed with 4% paraformaldehyde, rinsed in PBT three times, and incubated with hybridization buffer (50% formamide, 5ϫ SSC, pH 4.5, 1% SDS, 50 g /ml heparin, and 50 g /ml yeast RNA). After the addition of probe (1000 ng /ml), slides were hybridized at 65°C overnight. Slides were rinsed in 50% formamide, 5ϫ SSC, pH 4.5, 1% SDS at 65°C for 30 min; in 50% formamide, 2ϫ SSC at 65°C three times for 30 min each; and with 25 mM Tris-HC l, pH 7.5, 0.8% NaC l, 0.02% KC l, 0.1% T ween 20 (TBST) at room temperature three times for 5 min each. Slides were submerged in the blocking buffer [0.5% blocking reagent (Roche) in TBST] at room temperature for 1 hr and then incubated in sheep anti-DIG antibody conjugated to alkaline phosphatase in the blocking buffer at 4°C overnight. Slides were rinsed with TBST containing 2 mM levamisole at room temperature three times for 20 min each. After a 5 min rinse in 0.1 M NaC l, 50 mM Tris, pH 9.5, 50 mM MgC l 2 , 0.1% T ween 20, and 2 mM levamisole, slides were developed in the dark in BM purple alkaline phosphatase substrate solution (Roche) containing 2 mM levamisole for 2 d. The development was stopped by rinsing several times with 10 mM Tris and 1 mM EDTA.
In Northern blot analysis, total RNA was isolated from several mouse brain regions, dissected under a microscope, and electrophoresed on a 1% agarose gel in the presence of 2.2 M formaldehyde. Then the RNA was transferred onto positively charged nylon membranes (Roche) and hybridized with the DIG-labeled RNA probes in DIG Easy Hyb (Roche) for 16 hr at 68°C. The membrane was washed twice for 5 min at room temperature with 2ϫ SSC and 0.1% SDS and then washed twice for 15 min at 68°C with 0.1ϫ SSC and 0.1% SDS. In Northern blot analysis using 32 P-labeled DNA probes, the RNA was transferred onto Hybond N ϩ membrane (Amersham Biosciences, Arlington Heights, IL) and hybridized in a solution containing 50% formamide for 16 hr at 42°C. The membrane was washed twice for 15 min at room temperature with 1ϫ SSC and 0.1% SDS and then washed twice for 15 min at 68°C with 0.25 or 0.1ϫ SSC and 0.1% SDS. The DNA probes were labeled using [␣- 32 P]dC TP and the Rediprime II random prime labeling system (Amersham Biosciences). The templates of the 32 P-labeled DNA probes were PCR-amplified fragments between 324 and 1461 bp of mouse xC T cDNA and 221 and 1478 bp of mouse 4F2hc cDNA, respectively.
In reverse transcription PCR (RT-PCR), the first-strand cDNA was synthesized from 1 g of the total RNA isolated from several mouse brain regions dissected under a microscope using oligo-dT 12-18 as a primer. PCR amplification of the cDNA was performed using the primer set 5Ј-C TCGTGACAGC TGTGGGCAT-3Ј and 5Ј-GGCAC TAGAC TCAA-GAACTGTG-3Ј, corresponding to the nucleotide sequences of mouse xCT (GenBank/European Molecular Biology Laboratory/DNA Databank of Japan accession no. AB022345).
The experimental procedures involving animals were approved by the University of Tsukuba Animal C are and Use Committee and were done in accordance with its guidelines.
RESULTS
Expression of xCT and 4F2hc mRNAs in the mouse brain was investigated by nonisotopic in situ hybridization using DIGlabeled riboprobes. The antisense probes for both xCT (a Bam-HI-HindIII fragment of 886 -1843 bp) and 4F2hc (a PstI-EcoRI fragment of 948 -1793 bp) detected their mRNA expression in some brain regions, whereas the sense probes used as negative controls gave rise to no signal (Figs. 1, 2) . As shown in Figure  1 A-D, both xCT and 4F2hc mRNAs were robustly expressed in approximately one-half of the cells in the area postrema (AP) and in one of the circumventricular organs (CVOs); weaker expression of these mRNAs was observed in the nucleus of the solitary tract. Positive signals for both xCT and 4F2hc were also detected in the subfornical organ (SFO), another CVO (Fig. 2) . In addition, the 4F2hc signal was detected in the choroid plexus, cerebellum, brainstem, and thalamus, whereas the signal for xCT was hardly detected in these regions (Figs. 1, 2 ). Besides CVOs, strong expression of xC T mRNA was observed in the ependymal cells located in the single layer of the ventricular wall adjacent to the ventromedial hypothalamic area (Fig. 3A,B) . Expression of the 4F2hc mRNA was also detected in the ependymal cells in the same region (Fig. 3D,E) . In the hypothalamic area, positive signals for both xCT and 4F2hc were observed in the scattered cells (Fig.  3C,F ) , although it remains undetermined which cell types are expressing these mRNAs. Strong expression of xCT was detected in medial habenular nuclei and paraventricular thalamic nuclei facing the dorsal third ventricle (Fig. 4 A,C) , whereas the 4F2hc signal was more broadly detected in these regions (Fig. 4 B,D) .
Outside the brain parenchyma, the meninges showed high levels of expression of xCT and 4F2hc mRNAs (Fig. 5) . Figure  5A -D shows representative examples of xC T and 4F2hc mRNA expression in the meninges lining the surface of the posterior colliculus and cerebellum. Judging from the distribution of the signal, xCT and 4F2hc expression appears to be present in the arachnoid and pia matters (Fig. 5C,D) . In other areas, such as the one ventral to the hypothalamus, the signals for both xCT and 4F2hc were strongly detected in the meninges but not in the cells of the large blood vessels (Fig. 5E,F ) . To investigate the ontogeny of xCT mRNA expression, we performed in situ hybridization of the embryonic mouse brain. The signal for xCT mRNA was detected primarily in the meninges surrounding the brain of the embryonic day 15 mouse, with especially high expression in the olfactory bulb (Fig. 6 A,B) and in the subarachnoid space of the cisterna magna (Fig. 6C,D) . The signal of 4F2hc mRNA was detected throughout the brain regions, including the meninges (data not shown).
To test the specificity of the data obtained in the above experiments, we have adopted two different approaches. First, we performed in situ hybridization using another set of antisense and sense probes for xCT (a PstI fragment of 34 -369 bp), which do not overlap with those used in Figures 1-6 . The antisense probe for xCT detected the signal in the AP, whereas the sense probe did not give any signal (Fig. 7) . This result is identical to the one obtained using the original probes. Next, we performed Northern blot analysis using the total RNA isolated from mouse brains. To this end, we carefully dissected five small regions from the adult mouse brain under a microscope, and total RNA was isolated. These RNAs were hybridized with the DIG-labeled RNA probes, which were used in the in situ hybridization experiments in this study, and also with the 32 P-labeled DNA probe used previously (Sato et al., 1999) . Both probes detected a strong signal in the meninges (Fig. 8 A) , which is in accordance with the high expression of xCT in the meninges in the in situ hybridization experi- ments. As shown previously, mRNA for xCT is expressed as the multiple bands, ϳ12, 3.5, and 2.5 kb, which probably represent alternative splicing, alternative polyadenylation sites, or a combination of both. The prominent 12 kb band has been suggested to represent mRNA with long 3Ј-untranslated regions (Sato et al., 1999 (Sato et al., , 2000 . The size of the band is the same as the one observed in the activated macrophage used as a positive control. Weak expression was detected in the hypothalamus and the cerebral cortex, and very faint signals were observed in the cerebellum and choroid plexus (Fig. 8 A) . The 4F2hc signal was detected in all of the areas examined, which is also compatible with the data obtained in the in situ hybridization experiments. To confirm the results of the Northern blot analysis, we performed RT-PCR using the total RNA from the five small regions from the adult mouse brain (Fig. 8 B) . A strong signal was detected in the meninges; weak expression was detected in the hypothalamus and the cerebral cortex. Very faint signals were observed in the cerebellum and choroid plexus. These results are consistent with those of the Northern blot analysis. The strong signal of the macrophage sample is thought to be attributable to the relatively large amount of smaller mRNAs for xCT (3.5 and 2.5 kb) in the macrophages (Sato et al., 1999) .
DISCUSSION
In the present study, we have demonstrated that xCT and 4F2hc mRNAs are especially abundant in several regions facing the CSF. Thus, it is likely that system x c Ϫ in these regions contributes to the clearance of cystine from the CSF. Cysteine and cystine, or glutathione and glutathione disulfide, are the critical components as cellular redox buffers in metabolism and homeostasis (Deneke, 2000) . In the blood plasma, cysteine and cystine are the main redox components, and the ratio of cysteine/cystine is kept constant (Kleinman and Richie, 2000) . The total concentration of free cysteine and cystine in the plasma is ϳ120 M (as halfcystine), and 10 -20% of the total is present as the reduced form (Bannai, 1984b; Andersson et al., 1995) , although some disturbance was observed in patients with end-stage renal failure (Wlodek et al., 2001) . In contrast, the data available for the concentration of cysteine and cystine in the CSF are limited. Only total cystine (cystine plus cysteine) was determined and was reported to be 0.25-1.3 M in human CSF (Lakke and Teelken, 1976; Araki et al., 1988) . Recently, using the thiol-specific fluorogenic reagent, the concentration of cysteine in human CSF was determined to be ϳ2.5 M (Castagna et al., 1995) . In rats, the concentration of cysteine in CSF has been demonstrated to be ϳ4 M (Anderson et al., 1989) . Wang and Cynader (2000) have shown that the concentration of cysteine in the CSF of rats ranges from 0.68 to 1.75 M (average, 1.12 M), whereas cystine is not detected. Together, the ratio of cysteine to cystine in CSF is very high compared with that in plasma. Data for the auto-oxidation rate of cysteine in the CSF are not available; the stability of cysteine in the CSF remains to be investigated. Data for the glutathione level in CSF are also limited; the reported values are very variable. Concentrations of glutathione in rat and human CSF are ϳ5-6 M (Anderson et al., 1989; Wang and Cynader, 2000) and 0.2-0.3 M (Castagna et al., 1995; Konings et al., 1999) , respectively. In the brain, reactive oxygen species are produced at a higher rate because of the high consumption of oxygen. Recent studies have suggested that the reactive oxygen species are involved in the pathogenesis of various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (Bains and Shaw, 1997) . Because cerebral ventricles, meninges, and the extracellular space in the parenchyma are filled with CSF, the antioxidant potential of CSF seems to be important. The cysteine/cystine balance may serve as a major redox buffer in the CSF. Clearance of cystine via system x c Ϫ in the cells facing the CSF and release of cysteine from the cells via neutral amino acid transporter(s) may contribute to maintaining the reduced state in the CSF against the oxidative stress. Figure 9 shows the hypothetical model for system x c Ϫ in maintaining the redox state of the CSF; a similar model has long been established in the cell-culture system (Bannai et al., 1989) . System x c Ϫ is an exchange agency, and the anionic form of cystine is transported in exchange for glutamate. The exchange is obligatory, with a molar ratio of 1:1. One of the glutamate transporters, GLAST (also called EAAT 1), is expressed in the AP, SFO, and meninges (Berger and Hediger, 2000) . This transporter may contribute to the reabsorption of glutamate effluxed from the cells in exchange for cystine via system x c Ϫ . CVOs are highly vascularized structures; they possess unusual vascular arrangements, with many capillary loops reaching near the ventricular surface (Oldfield and McKinley, 1995) . These capillaries have fenestrated endothelial cells, resulting in local disruption of the blood-brain barrier. AP and SFO contain receptors or binding sites for many peptides, including angiotensin, and participate in the general regulation of fluid balance and blood pressure (Fitzsimons, 1998) . In addition, these regions contain neuronal perikarya and are referred to as the sensory CVOs (Johnson and Gross, 1993) . They have extensive afferent and efferent neural networks between the CVOs and other brain structures. There can be bidirectional movement of polar molecules between the blood, the CSF, and the brain parenchyma. Thus, these regions may be allowed to detect small changes in circulating hormones, peptides, and neuroactive substances and to respond hormonally and neurally to these signals. System x c Ϫ expressed in the SFO and the AP may function as the sensor for the redox balance between cysteine and cystine in the blood and/or the CSF. 4F2hc functions as the common component not only for system x c Ϫ but also for systems L and y ϩ L to elicit their activities (Verrey et al., 2000) . In our study, 4F2hc mRNA was detected in all of the areas in the mouse brain where xCT mRNA was expressed, including the AP, SFO, lateral wall of the third ventricle, medial habenular nuclei, and meninges. 4F2hc mRNA was also detected in areas such as the hippocampus, choroid plexus, cortex, and cerebellum. Thus, 4F2hc may be coupled with other partners to elicit different transporter activities. Among the transporters that require 4F2hc for the expression of their transporter activity, L-type amino acid transporter-2 (LAT-2) mediates the transport for neutral amino acids, including cysteine; its mRNA is detected in the brain (Segawa et al., 1999) . It is likely that LAT-2 mRNA is expressed in the areas where 4F2hc mRNA is detected and that the activity of system L is expressed in those areas. Although the significant signal of xCT mRNA was not detected in the cortex or cerebellum by our nonisotopic in situ hybridization, the results do not exclude the possibility that a low level of xCT mRNA is expressed in these areas. Indeed, very weak signals were detected in these brain areas by Northern blot analysis and Figure 8 . Expression of xCT and 4F2hc mRNAs in various areas of the adult mouse brain. A, Northern blot analysis of xCT and 4F2hc. Total RNA (1.5 g) isolated from the choroid plexus, hypothalamus, meninges, cortex, cerebellum, whole brain, and the mouse peritoneal macrophage cultured for 8 hr with 1 ng/ml bacterial lipopolysaccharide was loaded per lane. Hybridization was performed with DIG-labeled RNA probes or 32 P-labeled DNA probes for xCT, 4F2hc, and ␤-actin. The DIG-labeled RNA probes for xCT and 4F2hc are the same as those used in Figures  1-6 . B, RT-PCR of total RNA from the choroid plexus, hypothalamus, meninges, cortex, cerebellum, whole brain, and the mouse peritoneal macrophage cultured for 8 hr with 1 ng/ml bacterial lipopolysaccharide. The figure shows the ethidium bromide-stained agarose electrophoresis of the PCR products using the primer sets corresponding to the sequence of xCT (top) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; bottom). Figure 9 . Schematic model for the cystine/cysteine cycle in the subarachnoid space. Cystine (Cyss) in the CSF is taken up by system x c Ϫ and reduced to cysteine (CySH ), which is primarily used for glutathione (GSH ) synthesis; alternatively, it is taken out of the cell by neutral amino acid transporters. Although cysteine in the CSF is rapidly oxidized to cystine, it is cleared from the CSF in the subarachnoid space by the action of system x c Ϫ . Glu, Glutamate.
